Newspaper and internet articles, Random

Peter Needham (another victim) and yet another Coroner’s warning.

In March of last year, an Inquest was held into the death of  Peter Needham, 40 (a former British Aerospace inspector). Mr Needham was described as a normal, happy, sociable, lovely guy. His dad described him as ‘a beautiful son’. How did Peter (a sociable and popular man) get to the Inquest stage at 40? Very easily!

(1) 40-year-old Peter had been diagnosed with diabetes last March and prescribed a drug to deal with a tingling sensation in his foot. The medication he was prescribed is also used as an antidepressant. Duloxetine (aka Cymbalta) comes with warnings of suicidality, agression and depression. The sad fact is that at least 5 people killed themselves while trialing this drug in clinical trials for Eli-Lilly. This should have raised a red flag but no! The drug went on to be licenced and Eli-Lilly made billions. What’s a few bodies between drug companies?

(2) After voicing concerns about feeling down, Peter was prescribed a different anti-depressant, Sertraline, five days before his death. Sertraline (aka Zoloft) also comes with warnings of suicidality, aggression and depression. Pfizer discovered in their clinical trials that this drug also increased suicidal behavior and fared negatively in treating depression. Despite the negative results of these trials, Zoloft went on to be licensed and Pfizer made billions. What’s a few bodies between drug companies? Just ask Woody.

(3) Two days after taking Sertraline/Zoloft, Peter started to visit websites on how to take his own life.

(4) Five days after taking Sertraline/Zoloft, Peter hanged himself at his home in Springhead.

The Coroner (Simon Nelson) said it was “difficult to ignore” the link between Peter taking the medication and his death. He said that he would write to the Royal Pharmaceutical Society and British Medical Association to raise his concerns about prescription-medicine labelling.

Holding up a page filled with small-print instructions, he said: “To the untrained eye and in particular the first-time user this would be completely off-putting. To discover those warnings half way down the small print is wholly inappropriate.”

Six weeks later another Inquest was held, this time in Ireland, which involved the same drug, only this time it was Nicolas Maguire, 52, from County Cork.

So another Coroner’s warning and the governments are still doing nothing? How many people have died today because these useless, spineless, pen-pushers are not doing their job? That includes our own Kathleen Lynch and James Reilly!


Prozac, Eli-Lilly and bribing the Swedish government.

“I bribed the Swedish Government to get the licence for Prozac”. These are the words of Dr. John Virapen who worked in the pharmaceutical industry for over 35 years.  I have written about Dr. Virapen before because he told me about the corruption he got up to when he worked for Lundbeck. Anyway before he was employed by Lundbeck he worked for Eli-Lilly who are the manufacturers of Prozac. He refers to bribing Swedish officials because Eli-Lilly told him his job depended on it. He also says that the pharmaceutical industry have been buying doctors, picking them up in medical scool and paying their tuition to influence their prescribing. His new you-tube video is here. Link.

He was at one stage in charge of a clinical study for Prozac in one of the largest hospitals in Stockholm. The first week of the trial two of the volunteers tried to commit suicide which he admits is a well known side-effect of ssri medication.

He says that the pharmaceutical industry is now trying to target children with these drugs, Strattera, Prozac, Ritalin, Paxil, Zoloft, Ect. and that hand picked psychiatrists, paid for by the pharma industry, meet once a year to come up with new “disorders”. (unetical psychiatrists? No way!)

He says in one year 157 people were either killed or seriously injured by Strattera, among the victims was a 3 year old girl.

Eli-Lilly; NY Times continues spotlight on Eli-Lilly corruption. Zyprexa deaths and Ghostwriting.

Eli Lilly treated the American public “like guinea pigs” says Harvard psychiatrist. 
Eli-Lilly cases on Professor Healy’s website…                                                                                                                                                   
Let them eat Prozac.                                                                                                                                                                                                                                                 


Scientist weeps at inquest into Prozac death.  Professor Hay told the coroner he was looking into the role of Prozac in his wife’s illness and whether the standard one-a-day 20mg dose was too much for some people.

Prozac killed my wife.

Eli Lilly, the manufacturers of Prozac, gave the usual Inquest statement: “There is no credible scientific evidence that establishes a causal connection between Prozac and violent or suicidal behaviour.”

So tell me, what do our politicians and IDA officials talk about when they meet up with Eli-Lilly personel? Looks like there having fun. I guess they’re not talking about Maria’s son Toran, who was 17 when he killed himself on Prozac. Link. Or maybe the murder/suicide of William and June Forsyth in Hawaii?  Link. Or was it the upcoming Prozac murder trial tommorrow? Link. What about the Wesbecker Trial which Eli-Lilly secretly settled while the trial was ongoing, or maybe they talked about Tracy Johnson the 19 year old volunteer who killed herself in the Lilly Lab during a drug trial? Link. No? Didn’t think so!

cipramil (celexa) stories,, lundbeck

Ulf Wiinberg,Teddy Hebo Larsen, and 3 antidepressants.(effexor, cipramil and Prozac)

It seems unbelievable to me that there is still plenty of controversy surrounding antidepressants and whether they can cause some people to commit suicide and homicide, despite the (admittedly encrypted) information listed on the patient information leaflets (PIL) and experts like Professor David Healy proving the same.

Ulf Winberg is the ceo of lundbeck who as I’ve already said, sent a statement to RTE news on the day of my son’s inquest, stating that cipramil/celexa could not cause someone to commit suicide or homicide.

Now here’s an interesting fact about Ulf, before becoming the ceo/president of lundbeck he worked for Wyeth for 27 years, so one can assume he was familiar with Wyeth’s own antidepressant Effexor and the class action (Link), suicides, murder suicides and birth defect cases relating to this drug.

An interesting fact with Effexor is that homicide ideation is a listed side-effect on the patient information leaflet and shown on the picture above…Link and even more telling is the fact that the word “suicidal” appears in the same PIL 42 times. Hows that for a supposedly happy pill?

Effexor is prescribed here in Ireland but known as Efaxil XL and not surprisingly there is no mention of homicidal ideation in the Irish PIL.

One of the cases in the class action is reported on an English website, ssri uk support (Link) and involves Raymond Noll, 58, a man with no history of violence and 2 days on Effexor…

Raymond Noll, 58, (Effexor) a man with no history of violence, complained to his doctor of “difficulty sleeping, anxiety and worsening depression” on July 1st 2003 and was prescribed Effexor. The following evening his wife, Cynthia, called their son Tony to ask him if he would visit as “Dad was getting bad” but wanted first to see how he was by morning and said that she would phone Tony again. Then,  at 7.45 on 3rd July, a 911 operator received a call from Raymond saying, “I have just killed my wife and by the time you get here I will kill myself.” Raymond had shot his wife and himself and both bodies were found on the bed, the bottle of Effexor was found with the two previous days’ pills missing. The call Tony received that morning was not from his mother but from the Police who told him that both his parents were dead.


What do you think Ulf? Does it remind you of or seem very similar to the on-going cipramil/celexa case in America where Robert Raines (78) shot himself and his wife Elsie (71) after 5 days on celexa? Link

Update 14/07/2011

Two weeks ago Lundbeck’s Teddy Hebo Larsen was appointed as Senior Vice President of HR, second in command to Mr.Wiinberg. He had been with Lundbeck for the last two years, having previously been employed with Eli-Lilly for 23 years. 

Now I’m sure they must have conversed somewhat in the last two years about the side effects of these drugs and I wonder if Teddy mentioned the fact that Eli-Lilly knew Prozac had a reported 1200% higher suicide rate than other antidepressants? Did he mention Tracy Johnson? Tracy was a 19 year old student who was taking part in a trial for Eli-Lilly’s Cymbalta (Prozac’s chemical cousin) when she hung herself in the bathroom of an Eli-Lilly lab. This girl was not depressed, killed herself and the drug was approved anyway!

Did Teddy ever come across John Virapen? Dr. John Virapen Ph.D. is a Former Eli Lilly executive who admits to bribing a Swedish professor to enhance the registration of Prozac in Sweden. He also admits that there have been years of withheld information regarding the adverse side effects of pharmaceuticals promoted by Eli Lilly, including the role Prozac played in inducing suicide and homicide. The signs of drug induced violence and suicidality were there since Prozac was first tested in pre-marketing trials. John states that more than 75 percent of leading scientists in the field of medicine are paid for by the pharmaceutical industry.

John also worked for Lundbeck and has told me personally about the dodgy dealings he got up to while working for them, but hey that’s a story for another day!

Prozac and the William Forsyth murder/suicide.

Effexor and the raymond and cynthia noll murder/suicide.

Cipramil and the Richardson family murder/suicide.

Eli-Lilly and “The connection between violence, suicide, homicide, and antidepressants”. Link.

Newspaper and internet articles

Traci Johnson

Was Traci Johnson driven to suicide by anti-depressants? That’s a trade secret, say US officials

Sunday, 19 June 2005

Researchers trying to establish the truth about a new drug – now on sale in the UK – are being thwarted by a government agency whose job is to protect the public

By Jeanne Lenzer and Nicholas Pyke

When the body of a 19-year-old student, Traci Johnson, was found hanging from a shower rod in the laboratories of pharmaceuticals giant Eli Lilly, US officials were quick to announce that the death could not be linked to a new anti-depressant drug she was helping to test.

During her stay at the hotel-cum-clinic in Indiana known as the Lilly Lab, Johnson had been taking part in trials for a secret new formula called Cymbalta, a chemical cousin of Prozac, which the company hoped would guarantee huge profits for years to come.

For the drugs giant, her death on 7 February last year was an “isolated tragedy” that did not prevent it from pressing ahead with the Cymbalta trials. It is now on sale in the US and – under another name – in Europe and the UK.

But for the scientific community it was another warning bell about a class of medicines already under scrutiny for possible ties to suicide. After all, Johnson was not depressed. Far from it. She enrolled in the clinical trial as a healthy volunteer in order to earn money to pay for her college tuition. Anyone with signs of depression was excluded.

Now, medical researchers attempting to establish the truth about Cymbalta are asking why her disturbing and very public suicide is completely absent from the official record, at least as it is released to academics and the public. According to an investigation by The Independent on Sunday, this and at least four other suicides by volunteers have been hidden by the US regulators, the Food and Drug Administration (FDA).

As the FDA admits, even a young woman’s death counts as a commercial secret in the world of pharmaceuticals.

Last week, the IoS reported how vital data on prescription medicines found in millions of British homes has been suppressed by the US authorities, even though the information could potentially save lives. As a result, medical specialists say they have been unable to assess the true risks of big-name products such as painkillers Vioxx (now withdrawn) and Neurofen.

It is hard to overestimate the importance of Cymbalta to Eli Lilly. Prozac, the popular antidepressant that accounted for a quarter of the company’s $10bn revenues in 2000, went off-patent in August 2001, causing a bruising financial reaction on Wall Street. In just one day, the company’s stock plunged by almost a third.

The replacement was supposed to be Cymbalta, which financial analysts predicted would bring in a whopping $2bn in sales.

Lilly defended its drug, saying that 4,142 depressed patients had taken Cymbalta and the deaths represent a 0.097% suicide rate. Besides, it said, it is the underlying depression – not the drug – that causes sufferers to become suicidal.

With so much at stake, the FDA sent experts to Indianapolis to investigate. When they announced that Cymbalta “couldn’t be linked to her death”, her family was outraged. According to the Johnson family spokesperson, Pastor Joel Barnaby, FDA officials never spoke to them.

National headlines following the FDA ruling were unequivocal. The Associated Press ran an article entitled, “FDA clears Lilly drug in suicide”. And six months after Johnson’s death, the FDA approved the drug for the treatment of depressed patients. Cymbalta, which has the chemical name duloxetine, is also sold for “stress urinary incontinence” in Europe and the UK under the trade name Yentreve.

Beginning in January, the IoS started filing US Freedom of Information Act requests for all safety data relating to the drug’s use. The FDA responded with its Adverse Events Reporting System (Aers) database, which shows 13 suicides reported among patients taking duloxetine and about 41 deaths. Five suicides are notably absent from the information supplied by the FDA; that of Johnson and the four patients who committed suicide while enrolled in clinical trials of Cymbalta.

The FDA has a good reason not to release any information about these five patients: they don’t have to. In fact, it’s against the law, according to Dr Robert Temple, its director of medical policy. In an exclusive interview with the IoS, he said that some of the data filed by Lilly is considered commercially protected information.

When asked whether the FDA would release all the data from anti-depressant trials analysed by the FDA to a researcher, Dr Temple said his belief is that “the answer is clearly no”. That, he said, is something “only Congress can change”.

Dr David Graham, associate safety director at the FDA, agreed with Dr Temple that it would take action by Congress to make data available that are currently considered trade secrets. “Most of us think of trade secrets as a manufacturing process or the names of certain ingredients, but here, deaths are being considered trade secrets.”

Following revelations that drug companies were not publishing negative data, Eli Lilly won praise for its announcement that it would disclose all clinically relevant trial data on its website. The company has stated that it will disclose “all medical research results that are significant to patients, health care providers or payer – whether favourable or unfavourable to a Lilly product”.

The company posts clinical trials results on its freely available clinical trials website ( Data from seven trials of duloxetine are posted, but these show a total of two deaths associated with duloxetine, and no reported suicides. Lilly says that it is “on track” to post all clinical data by 1 July 2005.

A spokesman for Eli Lilly, David Shaffer, said some of the studies are still in progress and that the suicides would be reported when the studies are completed, the data is reviewed and, if applicable, they have been published in a peer-reviewed scientific journal. Other suicides occurred in depression studies “run by another company”. Two cases from a completed study will be posted by 1 July, he said.

Dr Jerome Hoffman, professor of medicine and emergency medicine at the University of California at Los Angeles said, “Like Dr Temple, I don’t know whether this one young woman’s death was related to this drug, nor do I believe that it’s possible for anyone to determine that with certainty.”

But he said it was “unconscionable” that “the FDA appears to be prevented by law from carrying out what we all surely believe is its primary role in this process, which is to safeguard the interests of the public.

“The fact that the law not only does not make this a requirement – of the drug company itself, no less of the FDA – but that it actually makes it forbidden, clearly turns the function of this government agency on its head: from protector of the public health, to protector of industry.”